Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 147 | 2024 | 5092 | 10.050 |
Why?
|
Lithium | 37 | 2024 | 596 | 4.580 |
Why?
|
Depressive Disorder, Major | 43 | 2024 | 4762 | 3.700 |
Why?
|
Suicide, Attempted | 35 | 2024 | 1402 | 3.040 |
Why?
|
Lithium Compounds | 20 | 2024 | 223 | 2.890 |
Why?
|
Antimanic Agents | 30 | 2024 | 520 | 2.870 |
Why?
|
Suicide | 28 | 2023 | 1602 | 2.840 |
Why?
|
Antidepressive Agents | 48 | 2024 | 2897 | 2.700 |
Why?
|
Mood Disorders | 19 | 2023 | 1127 | 2.670 |
Why?
|
Temperament | 14 | 2023 | 297 | 1.800 |
Why?
|
Suicidal Ideation | 12 | 2024 | 1447 | 1.700 |
Why?
|
Italy | 26 | 2021 | 842 | 1.330 |
Why?
|
Psychotropic Drugs | 7 | 2022 | 888 | 1.180 |
Why?
|
Lithium Carbonate | 12 | 2010 | 179 | 1.070 |
Why?
|
Antipsychotic Agents | 16 | 2024 | 3067 | 1.040 |
Why?
|
Depressive Disorder | 22 | 2020 | 3728 | 1.040 |
Why?
|
Anxiety Disorders | 11 | 2022 | 2720 | 0.920 |
Why?
|
Cyclothymic Disorder | 3 | 2014 | 42 | 0.860 |
Why?
|
Electroconvulsive Therapy | 7 | 2016 | 500 | 0.820 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 12 | 2023 | 1988 | 0.690 |
Why?
|
Appetite | 1 | 2022 | 247 | 0.680 |
Why?
|
Depression | 16 | 2022 | 8126 | 0.680 |
Why?
|
Age of Onset | 15 | 2023 | 3306 | 0.620 |
Why?
|
Psychiatry | 4 | 2018 | 1693 | 0.570 |
Why?
|
Psychopharmacology | 1 | 2019 | 148 | 0.570 |
Why?
|
Transients and Migrants | 1 | 2020 | 165 | 0.560 |
Why?
|
Anticonvulsants | 9 | 2024 | 1906 | 0.550 |
Why?
|
Resilience, Psychological | 1 | 2024 | 788 | 0.540 |
Why?
|
Humans | 201 | 2024 | 761596 | 0.540 |
Why?
|
Antidepressive Agents, Tricyclic | 3 | 2020 | 432 | 0.530 |
Why?
|
Argentina | 7 | 2020 | 246 | 0.530 |
Why?
|
Psychotic Disorders | 6 | 2018 | 3223 | 0.460 |
Why?
|
Adult | 92 | 2024 | 221210 | 0.460 |
Why?
|
Adaptation, Psychological | 2 | 2024 | 2629 | 0.450 |
Why?
|
Menarche | 1 | 2016 | 532 | 0.450 |
Why?
|
Drug Therapy | 1 | 2016 | 503 | 0.430 |
Why?
|
Borderline Personality Disorder | 1 | 2020 | 768 | 0.420 |
Why?
|
Risk Factors | 43 | 2024 | 74213 | 0.410 |
Why?
|
Micronutrients | 1 | 2015 | 382 | 0.410 |
Why?
|
Personality Inventory | 6 | 2022 | 1019 | 0.410 |
Why?
|
Psychiatric Status Rating Scales | 16 | 2023 | 6019 | 0.400 |
Why?
|
Weight Gain | 1 | 2022 | 2348 | 0.380 |
Why?
|
Internationality | 5 | 2019 | 1001 | 0.370 |
Why?
|
Female | 108 | 2024 | 392705 | 0.370 |
Why?
|
Reproductive Behavior | 1 | 2011 | 27 | 0.370 |
Why?
|
Male | 104 | 2024 | 360846 | 0.360 |
Why?
|
Emigrants and Immigrants | 1 | 2017 | 543 | 0.350 |
Why?
|
Substance Withdrawal Syndrome | 10 | 2010 | 625 | 0.340 |
Why?
|
Birth Rate | 1 | 2011 | 168 | 0.330 |
Why?
|
Irritable Mood | 3 | 2021 | 194 | 0.330 |
Why?
|
Siblings | 1 | 2013 | 825 | 0.330 |
Why?
|
Selection, Genetic | 1 | 2013 | 868 | 0.320 |
Why?
|
Mental Disorders | 4 | 2019 | 6845 | 0.310 |
Why?
|
Seasons | 5 | 2022 | 1520 | 0.300 |
Why?
|
Sex Distribution | 4 | 2020 | 2280 | 0.290 |
Why?
|
Multivariate Analysis | 8 | 2015 | 12059 | 0.290 |
Why?
|
Sex Factors | 19 | 2019 | 10554 | 0.280 |
Why?
|
Prevalence | 14 | 2023 | 15733 | 0.280 |
Why?
|
Treatment Outcome | 40 | 2019 | 64685 | 0.270 |
Why?
|
Middle Aged | 57 | 2024 | 220921 | 0.270 |
Why?
|
Comorbidity | 11 | 2018 | 10508 | 0.270 |
Why?
|
Puerperal Disorders | 3 | 2023 | 300 | 0.260 |
Why?
|
Family Characteristics | 1 | 2011 | 1004 | 0.250 |
Why?
|
Age Distribution | 3 | 2020 | 2879 | 0.250 |
Why?
|
History, 19th Century | 3 | 2018 | 720 | 0.250 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2018 | 3708 | 0.240 |
Why?
|
Health Personnel | 1 | 2018 | 3335 | 0.230 |
Why?
|
Substance-Related Disorders | 8 | 2019 | 4420 | 0.230 |
Why?
|
Sunlight | 3 | 2022 | 337 | 0.220 |
Why?
|
Drug Therapy, Combination | 12 | 2021 | 6312 | 0.210 |
Why?
|
Cross-Cultural Comparison | 3 | 2020 | 635 | 0.210 |
Why?
|
Anxiety | 4 | 2022 | 4573 | 0.210 |
Why?
|
Morbidity | 4 | 2021 | 1752 | 0.210 |
Why?
|
Drug Administration Schedule | 14 | 2010 | 4853 | 0.200 |
Why?
|
Recurrence | 23 | 2015 | 8466 | 0.190 |
Why?
|
Clinical Trials as Topic | 6 | 2014 | 8002 | 0.180 |
Why?
|
Valproic Acid | 2 | 2021 | 443 | 0.180 |
Why?
|
History, 20th Century | 4 | 2018 | 2767 | 0.180 |
Why?
|
Survival Analysis | 10 | 2022 | 10090 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 13 | 2022 | 10212 | 0.160 |
Why?
|
Schizophrenia | 3 | 2015 | 6937 | 0.160 |
Why?
|
History, Medieval | 1 | 2018 | 62 | 0.150 |
Why?
|
Severity of Illness Index | 10 | 2020 | 15843 | 0.150 |
Why?
|
Paranoid Disorders | 1 | 2018 | 61 | 0.150 |
Why?
|
History, 17th Century | 1 | 2018 | 108 | 0.150 |
Why?
|
Scopolamine | 3 | 1997 | 93 | 0.140 |
Why?
|
Schizophrenia, Paranoid | 1 | 2018 | 103 | 0.140 |
Why?
|
History, Ancient | 1 | 2018 | 212 | 0.140 |
Why?
|
Time Factors | 22 | 2024 | 39969 | 0.140 |
Why?
|
Cities | 1 | 2020 | 546 | 0.140 |
Why?
|
Interview, Psychological | 2 | 2011 | 809 | 0.140 |
Why?
|
Age Factors | 10 | 2019 | 18399 | 0.140 |
Why?
|
Demography | 2 | 2015 | 1648 | 0.140 |
Why?
|
Medication Adherence | 1 | 2008 | 2176 | 0.140 |
Why?
|
History, 18th Century | 1 | 2017 | 207 | 0.140 |
Why?
|
Self-Help Groups | 1 | 2017 | 192 | 0.130 |
Why?
|
Brazil | 1 | 2020 | 1230 | 0.130 |
Why?
|
Benzodiazepines | 3 | 2021 | 1132 | 0.130 |
Why?
|
Delusions | 1 | 2018 | 298 | 0.130 |
Why?
|
Adolescent | 18 | 2023 | 88326 | 0.130 |
Why?
|
Longitudinal Studies | 8 | 2022 | 14608 | 0.120 |
Why?
|
Ketamine | 2 | 2021 | 519 | 0.120 |
Why?
|
Psychometrics | 7 | 2018 | 3065 | 0.120 |
Why?
|
Behavioral Symptoms | 1 | 2016 | 186 | 0.120 |
Why?
|
Internet | 2 | 2017 | 3093 | 0.120 |
Why?
|
Personality | 2 | 2011 | 554 | 0.110 |
Why?
|
Follow-Up Studies | 16 | 2018 | 39106 | 0.110 |
Why?
|
Memantine | 1 | 2015 | 108 | 0.110 |
Why?
|
MMPI | 2 | 1991 | 81 | 0.110 |
Why?
|
Logistic Models | 4 | 2018 | 13255 | 0.110 |
Why?
|
Circadian Rhythm | 4 | 2022 | 2576 | 0.110 |
Why?
|
Patient Dropouts | 2 | 2014 | 412 | 0.110 |
Why?
|
Secondary Prevention | 7 | 2010 | 1475 | 0.110 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1993 | 139 | 0.110 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2014 | 186 | 0.110 |
Why?
|
Imipramine | 1 | 2012 | 98 | 0.110 |
Why?
|
Probiotics | 1 | 2017 | 378 | 0.100 |
Why?
|
Young Adult | 10 | 2023 | 59260 | 0.100 |
Why?
|
ROC Curve | 3 | 2019 | 3578 | 0.100 |
Why?
|
Risk Adjustment | 1 | 2016 | 600 | 0.100 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2012 | 156 | 0.100 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2015 | 448 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 1999 | 1787 | 0.100 |
Why?
|
Personality Assessment | 2 | 2011 | 650 | 0.100 |
Why?
|
Retrospective Studies | 13 | 2022 | 80647 | 0.100 |
Why?
|
Fluoxetine | 1 | 2015 | 733 | 0.090 |
Why?
|
Ejaculation | 1 | 1991 | 59 | 0.090 |
Why?
|
Family Health | 2 | 2015 | 1257 | 0.090 |
Why?
|
Panic Disorder | 2 | 2014 | 613 | 0.090 |
Why?
|
Disease Progression | 3 | 2024 | 13510 | 0.090 |
Why?
|
Gene Products, rev | 1 | 2010 | 29 | 0.090 |
Why?
|
Child | 12 | 2023 | 80158 | 0.090 |
Why?
|
Prospective Studies | 12 | 2023 | 54423 | 0.090 |
Why?
|
Causality | 1 | 2016 | 1242 | 0.090 |
Why?
|
Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2010 | 33 | 0.090 |
Why?
|
Placebo Effect | 1 | 2014 | 518 | 0.090 |
Why?
|
Risk Assessment | 9 | 2014 | 23996 | 0.080 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 1991 | 189 | 0.080 |
Why?
|
Thyrotropin | 1 | 1993 | 834 | 0.080 |
Why?
|
Panic | 1 | 1989 | 103 | 0.080 |
Why?
|
Sexuality | 1 | 2011 | 180 | 0.080 |
Why?
|
Fatty Acids | 1 | 2017 | 1808 | 0.080 |
Why?
|
Phenotype | 2 | 2024 | 16592 | 0.080 |
Why?
|
Growth Hormone | 1 | 1991 | 569 | 0.080 |
Why?
|
Physician-Patient Relations | 1 | 2022 | 3251 | 0.080 |
Why?
|
Health Services Accessibility | 1 | 2006 | 5440 | 0.080 |
Why?
|
Carbamazepine | 1 | 1989 | 224 | 0.080 |
Why?
|
Europe | 4 | 2017 | 3420 | 0.080 |
Why?
|
Psychotherapy | 2 | 2023 | 1647 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2024 | 22176 | 0.070 |
Why?
|
Aged | 15 | 2020 | 169310 | 0.070 |
Why?
|
Erectile Dysfunction | 1 | 1991 | 444 | 0.070 |
Why?
|
Hydrocortisone | 2 | 1993 | 1819 | 0.070 |
Why?
|
Periodicity | 3 | 2000 | 348 | 0.070 |
Why?
|
Affect | 2 | 2013 | 1486 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1809 | 0.070 |
Why?
|
Ecology | 1 | 2007 | 104 | 0.070 |
Why?
|
Caffeine | 1 | 1991 | 700 | 0.070 |
Why?
|
Long-Term Care | 4 | 2007 | 633 | 0.070 |
Why?
|
Citalopram | 1 | 2009 | 402 | 0.070 |
Why?
|
Cluster Analysis | 2 | 2024 | 2707 | 0.070 |
Why?
|
Advisory Committees | 3 | 2015 | 787 | 0.070 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2009 | 489 | 0.070 |
Why?
|
Pindolol | 1 | 1985 | 34 | 0.070 |
Why?
|
Emotions | 1 | 2018 | 2739 | 0.070 |
Why?
|
Hospitalization | 4 | 2015 | 10721 | 0.070 |
Why?
|
Bayes Theorem | 1 | 2014 | 2330 | 0.070 |
Why?
|
Sleep | 2 | 1993 | 4768 | 0.070 |
Why?
|
Fertility | 1 | 2011 | 771 | 0.070 |
Why?
|
Risk | 3 | 2010 | 9610 | 0.060 |
Why?
|
Sleep, REM | 3 | 1997 | 595 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 1702 | 0.060 |
Why?
|
Odds Ratio | 3 | 2010 | 9647 | 0.060 |
Why?
|
Dexamethasone | 1 | 1993 | 1948 | 0.060 |
Why?
|
Population Density | 1 | 2006 | 193 | 0.060 |
Why?
|
Psychological Tests | 1 | 1988 | 640 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5890 | 0.060 |
Why?
|
Censuses | 1 | 2006 | 202 | 0.060 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1985 | 242 | 0.060 |
Why?
|
Coffee | 1 | 2009 | 593 | 0.060 |
Why?
|
Postpartum Period | 1 | 2011 | 1175 | 0.060 |
Why?
|
Unemployment | 3 | 1991 | 210 | 0.060 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 26129 | 0.060 |
Why?
|
Language | 1 | 2014 | 1543 | 0.060 |
Why?
|
Calcium Channels | 1 | 2008 | 620 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2009 | 7828 | 0.060 |
Why?
|
Placebos | 2 | 2006 | 1667 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12690 | 0.060 |
Why?
|
Stress, Psychological | 1 | 1999 | 4481 | 0.050 |
Why?
|
Pregnancy Complications | 2 | 2011 | 2947 | 0.050 |
Why?
|
Financing, Government | 1 | 2006 | 472 | 0.050 |
Why?
|
Societies, Medical | 1 | 2014 | 3905 | 0.050 |
Why?
|
Indians, North American | 1 | 2006 | 352 | 0.050 |
Why?
|
Drug Resistance | 1 | 2008 | 1596 | 0.050 |
Why?
|
Regression Analysis | 3 | 2010 | 6345 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2011 | 2095 | 0.050 |
Why?
|
Meta-Analysis as Topic | 1 | 2006 | 1380 | 0.050 |
Why?
|
Medically Uninsured | 1 | 2006 | 836 | 0.040 |
Why?
|
Fear | 1 | 1989 | 1477 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 2023 | 552 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2021 | 10766 | 0.040 |
Why?
|
Republic of Korea | 2 | 2011 | 590 | 0.040 |
Why?
|
Inpatients | 1 | 2011 | 2548 | 0.040 |
Why?
|
Sex Offenses | 1 | 2023 | 352 | 0.040 |
Why?
|
Prognosis | 8 | 2018 | 29629 | 0.040 |
Why?
|
Incidence | 3 | 2015 | 21355 | 0.040 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2023 | 701 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14665 | 0.040 |
Why?
|
Lebanon | 2 | 2011 | 245 | 0.040 |
Why?
|
Central Nervous System | 1 | 1985 | 1336 | 0.040 |
Why?
|
Factor Analysis, Statistical | 2 | 2014 | 999 | 0.040 |
Why?
|
Climate | 1 | 2019 | 147 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2006 | 1403 | 0.040 |
Why?
|
Solar System | 1 | 2017 | 12 | 0.040 |
Why?
|
Aggression | 1 | 2022 | 750 | 0.040 |
Why?
|
Personality Disorders | 2 | 2014 | 722 | 0.040 |
Why?
|
Electroencephalography | 1 | 1993 | 6237 | 0.040 |
Why?
|
Cause of Death | 2 | 2006 | 3683 | 0.040 |
Why?
|
Hospitals, Psychiatric | 1 | 1999 | 321 | 0.040 |
Why?
|
South America | 1 | 2017 | 179 | 0.040 |
Why?
|
Income | 1 | 2006 | 1877 | 0.040 |
Why?
|
Sleep Stages | 2 | 1993 | 694 | 0.040 |
Why?
|
Muscarinic Antagonists | 1 | 1997 | 135 | 0.030 |
Why?
|
Receptors, Cholinergic | 1 | 1997 | 244 | 0.030 |
Why?
|
Asia | 1 | 2017 | 619 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1638 | 0.030 |
Why?
|
Quality of Life | 1 | 2017 | 13367 | 0.030 |
Why?
|
Preventive Psychiatry | 1 | 2014 | 6 | 0.030 |
Why?
|
Africa | 1 | 2017 | 709 | 0.030 |
Why?
|
Models, Statistical | 1 | 2009 | 5079 | 0.030 |
Why?
|
Epilepsy | 1 | 2010 | 3290 | 0.030 |
Why?
|
Partial Thromboplastin Time | 1 | 1994 | 204 | 0.030 |
Why?
|
North America | 1 | 2017 | 1276 | 0.030 |
Why?
|
Australia | 1 | 2017 | 1250 | 0.030 |
Why?
|
Urban Population | 1 | 2021 | 2036 | 0.030 |
Why?
|
Greece | 1 | 2014 | 340 | 0.030 |
Why?
|
Crime | 1 | 2014 | 203 | 0.030 |
Why?
|
Seasonal Affective Disorder | 1 | 1993 | 49 | 0.030 |
Why?
|
Episode of Care | 1 | 2013 | 128 | 0.030 |
Why?
|
Health Care Costs | 1 | 2006 | 3242 | 0.030 |
Why?
|
Smoking | 1 | 2009 | 9053 | 0.030 |
Why?
|
Syndrome | 1 | 1999 | 3267 | 0.030 |
Why?
|
United States | 5 | 2011 | 72340 | 0.020 |
Why?
|
Impulsive Behavior | 1 | 2014 | 346 | 0.020 |
Why?
|
Chlorpromazine | 1 | 1991 | 111 | 0.020 |
Why?
|
Personality Development | 1 | 1991 | 244 | 0.020 |
Why?
|
Spain | 1 | 2011 | 487 | 0.020 |
Why?
|
Health Surveys | 2 | 2011 | 4061 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2417 | 0.020 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2019 | 1081 | 0.020 |
Why?
|
Reference Standards | 1 | 2014 | 1003 | 0.020 |
Why?
|
Reproducibility of Results | 4 | 2014 | 20100 | 0.020 |
Why?
|
Pregnancy | 4 | 2011 | 29890 | 0.020 |
Why?
|
Haloperidol | 1 | 1991 | 389 | 0.020 |
Why?
|
Delphi Technique | 1 | 2013 | 846 | 0.020 |
Why?
|
Cohort Studies | 2 | 2009 | 41495 | 0.020 |
Why?
|
Drug Combinations | 1 | 2015 | 2048 | 0.020 |
Why?
|
Agoraphobia | 1 | 1989 | 177 | 0.020 |
Why?
|
Brain | 2 | 2015 | 27121 | 0.020 |
Why?
|
France | 1 | 2010 | 497 | 0.020 |
Why?
|
Research Design | 2 | 2004 | 6180 | 0.020 |
Why?
|
International Cooperation | 1 | 2014 | 1422 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2013 | 909 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2006 | 5337 | 0.020 |
Why?
|
Rome | 1 | 2007 | 28 | 0.020 |
Why?
|
Patient Selection | 1 | 2000 | 4244 | 0.020 |
Why?
|
Physicians | 1 | 2006 | 4591 | 0.020 |
Why?
|
Reaction Time | 2 | 1997 | 2089 | 0.020 |
Why?
|
Dysthymic Disorder | 1 | 2007 | 75 | 0.020 |
Why?
|
Translations | 1 | 2007 | 81 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2013 | 1192 | 0.020 |
Why?
|
Pharmacoepidemiology | 1 | 2010 | 350 | 0.020 |
Why?
|
Betaxolol | 1 | 1985 | 1 | 0.020 |
Why?
|
Alprenolol | 1 | 1985 | 8 | 0.020 |
Why?
|
Clenbuterol | 1 | 1985 | 9 | 0.020 |
Why?
|
Propanolamines | 1 | 1985 | 163 | 0.020 |
Why?
|
Peer Review | 1 | 2007 | 217 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2005 | 303 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2010 | 803 | 0.010 |
Why?
|
Self Report | 1 | 2016 | 3725 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2217 | 0.010 |
Why?
|
Genotype | 2 | 2010 | 12990 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2007 | 945 | 0.010 |
Why?
|
Outpatients | 1 | 2012 | 1597 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1985 | 2088 | 0.010 |
Why?
|
Mathematics | 1 | 1985 | 707 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1985 | 1141 | 0.010 |
Why?
|
Isotope Labeling | 1 | 1985 | 392 | 0.010 |
Why?
|
Propranolol | 1 | 1985 | 489 | 0.010 |
Why?
|
Drug Approval | 1 | 2011 | 814 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5872 | 0.010 |
Why?
|
Consensus | 1 | 2013 | 3124 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1505 | 0.010 |
Why?
|
Genetic Markers | 1 | 2010 | 2601 | 0.010 |
Why?
|
International Classification of Diseases | 1 | 2009 | 910 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2850 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17904 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3415 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2008 | 1998 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2358 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1991 | 6228 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1994 | 2330 | 0.010 |
Why?
|
Checklist | 1 | 2009 | 827 | 0.010 |
Why?
|
Patient Admission | 1 | 2009 | 1367 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1985 | 2264 | 0.010 |
Why?
|
Administration, Oral | 1 | 2009 | 4021 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2010 | 12463 | 0.010 |
Why?
|
Employment | 1 | 1987 | 1118 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2011 | 2639 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2006 | 2927 | 0.010 |
Why?
|
Brain Stem | 1 | 1985 | 858 | 0.010 |
Why?
|
Animals | 3 | 2021 | 168475 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4243 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6864 | 0.010 |
Why?
|
Cerebellum | 1 | 1985 | 1501 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7968 | 0.010 |
Why?
|
Spinal Cord | 1 | 1985 | 1819 | 0.010 |
Why?
|
Gene Expression | 1 | 2008 | 7581 | 0.010 |
Why?
|
Genetic Variation | 1 | 2010 | 6567 | 0.010 |
Why?
|
Affective Symptoms | 1 | 1976 | 417 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12794 | 0.010 |
Why?
|
Informed Consent | 1 | 1999 | 1008 | 0.010 |
Why?
|
Polysomnography | 1 | 1997 | 1848 | 0.010 |
Why?
|
Postoperative Period | 1 | 1994 | 1814 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1985 | 5779 | 0.010 |
Why?
|
Rats | 1 | 1985 | 23741 | 0.010 |
Why?
|
Receptors, Muscarinic | 1 | 1989 | 157 | 0.000 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 15936 | 0.000 |
Why?
|
Probability | 1 | 1993 | 2477 | 0.000 |
Why?
|
Hypochondriasis | 1 | 1987 | 93 | 0.000 |
Why?
|
Erythrocytes | 1 | 1976 | 2413 | 0.000 |
Why?
|
Terminology as Topic | 1 | 1993 | 1530 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2000 | 15266 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1997 | 12341 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2008 | 58984 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1993 | 2775 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1993 | 12973 | 0.000 |
Why?
|
Remission, Spontaneous | 1 | 1977 | 384 | 0.000 |
Why?
|
Drug Interactions | 1 | 1981 | 1416 | 0.000 |
Why?
|
Functional Laterality | 1 | 1977 | 2257 | 0.000 |
Why?
|